Lasso peptide Felipeptin A1

General Information


DRACP ID  DRACP04565

Peptide Name   Lasso peptide Felipeptin A1

Sequence  GSRGWGFEPGVRCLIWCD

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Bacteria

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  6XTH 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C91H132N26O24S2

Absent amino acids  AHKMNQTY

Common amino acids  G

Mass  234174

Pl  6.23

Basic residues  2

Acidic residues  2

Hydrophobic residues  6

Net charge  0

Boman Index  -2093

Hydrophobicity  -8.33

Aliphatic Index  59.44

Half Life 
  Mammalian: 4.4 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  11125

Absorbance 280nm  654.41

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33294793

Title  Class IV Lasso Peptides Synergistically Induce Proliferation of Cancer Cells and Sensitize Them to Doxorubicin

Doi Not available

Year  0

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20590

DRACP is developed by Dr.Zheng's team.